Genetics of melanoma progression: the rise and fall of cell senescence (Q38589518)

4 September 2017

title

Genetics of melanoma progression: the rise and fall of cell senescence (English)

1 reference

4 September 2017

Dorothy C Bennett

1

0 references

publication date

19 September 2015

1 reference

Pigment Cell & Melanoma Research

4 September 2017

published in

1 reference

4 September 2017

volume

29

1 reference

4 September 2017

issue

2

1 reference

4 September 2017

page(s)

122-140

1 reference

A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

The atr protein kinase controls UV-dependent upregulation of p16INK4A through inhibition of Skp2-related polyubiquitination/degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Genetics of familial melanoma: 20 years after CDKN2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Telomeres and telomerase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

The human melanocyte: a model system to study the complexity of cellular aging and transformation in non-fibroblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Dynamic assembly of chromatin complexes during cellular senescence: implications for the growth arrest of human melanocytic nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Fine mapping of genetic susceptibility loci for melanoma reveals a mixture of single variant and multiple variant regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Human melanocyte senescence and melanoma susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

How to make a melanoma: what do we know of the primary clonal events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Molecular regulation of melanocyte senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

The signals and pathways activating cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Control of replicative life span in human cells: barriers to clonal expansion intermediate between M1 senescence and M2 crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Cancer cell senescence: a new frontier in drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

MC1R is a potent regulator of PTEN after UV exposure in melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Another option in our KIT of effective therapies for advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Telomerase activity in prognostic histopathologic features of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Stressing the cell cycle in senescence and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

A short acidic motif in ARF guards against mitochondrial dysfunction and melanoma susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Use of human tissue to assess the oncogenic activity of melanoma-associated mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

UV-induced expression of key component of the tanning process, the POMC and MC1R genes, is dependent on the p-38-activated upstream stimulating factor-1 (USF-1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Distinct sets of genetic alterations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Somatic activation of KIT in distinct subtypes of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Braf(V600E) cooperates with Pten loss to induce metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Oncogenic Braf induces melanocyte senescence and melanoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Clonal architectures and driver mutations in metastatic melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Receptor tyrosine kinases and their activation in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

COSMIC: exploring the world's knowledge of somatic mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

p16(INK) (4a) deficiency promotes DNA hyper-replication and genetic instability in melanocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

KIT as a therapeutic target in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

MDM4 is a key therapeutic target in cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Connecting mitotic instability and chromosome aberrations in cancer--can telomeres bridge the gap?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Cellular senescence in naevi and immortalisation in melanoma: a role for p16?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Melanomagenesis: overcoming the barrier of melanocyte senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

The serial cultivation of human diploid cell strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Regulation of growth arrest in senescence: telomere damage is not the end of the story

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Cellular senescence in aging primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

A landscape of driver mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Cancer stem cells versus phenotype-switching in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

TERT promoter mutations in familial and sporadic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Highly recurrent TERT promoter mutations in human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

High-throughput oncogene mutation profiling shows demographic differences in BRAF mutation rates among melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Germline p16 mutations in familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

The effect on melanoma risk of genes previously associated with telomere length

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

p16INK4a as a second effector of the telomere damage pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Review: a meta-analysis of GWAS and age-associated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Necessary and sufficient role for a mitosis skip in senescence induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

The essence of senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Forkhead box proteins: tuning forks for transcriptional harmony.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Discovery and saturation analysis of cancer genes across 21 tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Polyclonality of BRAF mutations in acquired melanocytic nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Alternative lengthening of telomeres is characterized by high rates of telomeric exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

BRAFE600-associated senescence-like cell cycle arrest of human naevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: a southwest oncology group study (S9431).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Cellular senescence: from physiology to pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Shorter telomeres associate with a reduced risk of melanoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Cellular senescence mediated by p16INK4A-coupled miRNA pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Feedback between p21 and reactive oxygen production is necessary for cell senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Wnt signaling potentiates nevogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Senescence: an antiviral defense that is tumor suppressive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

p16INK4A is a robust in vivo biomarker of cellular aging in human skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Improved overall survival in melanoma with combined dabrafenib and trametinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

POT1 loss-of-function variants predispose to familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Peripheral blood leukocyte telomere length and mortality among 64,637 individuals from the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Irreparable telomeric DNA damage and persistent DDR signalling as a shared causative mechanism of cellular senescence and ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Activation of nuclear factor-kappa B signalling promotes cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Genetic alterations in the tyrosine kinase transcriptome of human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Cellular senescence and its effector programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Histologic features of melanoma associated with CDKN2A genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Role of telomeres and telomerase in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Mutational status of naevus-associated melanomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Increased Risk of Cancer Other Than Melanoma in CDKN2A Founder Mutation (p16-Leiden)-Positive Melanoma Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

p16(Ink4a) in melanocyte senescence and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Functional neurons and melanocytes induced from immortal lines of postnatal neural crest-like stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Genomic Classification of Cutaneous Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Absence of distinguishing senescence traits in human melanocytic nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Extra copies of c-myc are more pronounced in nodular melanomas than in superficial spreading melanomas as revealed by fluorescence in situ hybridisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Melanoma: from mutations to medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Human cell senescence as a DNA damage response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Activation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Systematic classification of melanoma cells by phenotype-specific gene expression mapping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Genetic and epigenetic alterations of the APC gene in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FPCMR.12422

21 January 2018

Identifiers

DOI

10.1111/PCMR.12422

1 reference

4 September 2017

1 reference